Gene · 9782
Papers1,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human lncRNA SUGCT-AS1 Regulates the Proinflammatory Response of Macrophage. | Int J Mol Sci | 2023 | 37686120 | PubTator, text mining | PubMed |
| Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications. | Front Immunol | 2023 | 37671161 | PubTator, text mining | PubMed |
| Functional evolutionary convergence of long noncoding RNAs involved in embryonic development. | Commun Biol | 2023 | 37670146 | PubTator, text mining | PubMed |
| Targeted splicing therapy: new strategies for colorectal cancer. | Front Oncol | 2023 | 37664052 | PubTator, text mining | PubMed |
| Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis. | Front Neurosci | 2023 | 37638324 | PubTator, text mining | PubMed |
| The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer's Disease Reveals New Insights for AD Study. | Int J Mol Sci | 2023 | 37628788 | PubTator, text mining | PubMed |
| Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis. | J Neurol | 2023 | 37603075 | PubTator, text mining | PubMed |
| Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy. | Cells | 2023 | 37566027 | PubTator, text mining | PubMed |
| Cell-type specific regulator RBPMS switches alternative splicing via higher-order oligomerization and heterotypic interactions with other splicing regulators. | Nucleic Acids Res | 2023 | 37548402 | Swiss-Prot, curated | PubMed |
| Quantitative multiorgan proteomics of fatal COVID-19 uncovers tissue-specific effects beyond inflammation. | EMBO Mol Med | 2023 | 37519267 | PubTator, text mining | PubMed |
| SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer. | BMC Cancer | 2023 | 37464317 | PubTator, text mining | PubMed |
| Reviewing PTBP1 Domain Modularity in the Pre-Genomic Era: A Foundation to Guide the Next Generation of Exploring PTBP1 Structure-Function Relationships. | Int J Mol Sci | 2023 | 37446395 | PubTator, text mining | PubMed |
| The Continuous Adaptive Challenge Played by Arboviruses: An In Silico Approach to Identify a Possible Interplay between Conserved Viral RNA Sequences and Host RNA Binding Proteins (RBPs). | Int J Mol Sci | 2023 | 37446229 | PubTator, text mining | PubMed |
| Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2023 | 37445986 | PubTator, text mining | PubMed |
| Coarctation of the Aorta: Diagnosis and Management. | Diagnostics (Basel) | 2023 | 37443581 | PubTator, text mining | PubMed |
| Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues. | Aging (Albany NY) | 2023 | 37437245 | PubTator, text mining | PubMed |
| New insights on the interplays between m6A modifications and microRNA or lncRNA in gastrointestinal cancers. | Front Cell Dev Biol | 2023 | 37404673 | PubTator, text mining | PubMed |
| Characterizing proteomic and transcriptomic features of missense variants in amyotrophic lateral sclerosis genes. | Brain | 2023 | 37394881 | PubTator, text mining | PubMed |
| MATR3-antisense LINE1 RNA meshwork scaffolds higher-order chromatin organization. | EMBO Rep | 2023 | 37381832 | PubTator, text mining | PubMed |
| Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence. | Int J Mol Sci | 2023 | 37373500 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9782/papers?page=7